We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRO
1851
DELISTED
Marathon Oil Corporation
MRO
-358,263
Closed -$3.83M
JWSM.U
1852
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
-456,600
Closed -$4.63M
SEEL
1853
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-377
Closed -$7.22M
PRFT
1854
DELISTED
Perficient Inc
PRFT
-5,262
Closed -$309K
SILK
1855
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-5,011
Closed -$254K
CVIIU
1856
DELISTED
Churchill Capital Corp VII Units
CVIIU
-175,000
Closed -$1.75M
CERE
1857
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-48,583
Closed -$667K
NEXI
1858
DELISTED
NexImmune, Inc. Common Stock
NEXI
-960
Closed -$458K
EVBG
1859
DELISTED
Everbridge, Inc. Common Stock
EVBG
-83,699
Closed -$10.1M
MODN
1860
DELISTED
MODEL N, INC.
MODN
-7,791
Closed -$274K
ERF
1861
DELISTED
Enerplus Corporation
ERF
-60,606
Closed -$305K
AEL
1862
DELISTED
American Equity Investment Life Holding Company
AEL
-158,315
Closed -$4.99M
RMGCU
1863
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
-595,175
Closed -$5.92M
NGM
1864
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-55,953
Closed -$1.63M
JOAN
1865
DELISTED
JOANN, Inc. Common Stock
JOAN
-74,930
Closed -$761K
KRTX
1866
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-4,369
Closed -$526K
SIEN
1867
DELISTED
Sientra, Inc.
SIEN
-23,949
Closed -$1.75M
FLME.U
1868
DELISTED
Flame Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one Warrant
FLME.U
-105,000
Closed -$1.04M
IMGN
1869
DELISTED
Immunogen Inc
IMGN
-32,569
Closed -$264K
ORTX
1870
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-10,309
Closed -$748K
NM
1871
DELISTED
Navios Maritime Holdings Inc.
NM
-19,134
Closed -$168K
CZOO
1872
DELISTED
Cazoo Group Ltd
CZOO
-303
Closed -$6.22M
CCVI.U
1873
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
-25,000
Closed -$252K
APGB.U
1874
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
-700,000
Closed -$6.99M
APRN
1875
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
-1,995
Closed -$151K

Similar funds

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.